Jump to content

Sedoreoviridae

From Wikipedia, the free encyclopedia
(Redirected fromReovirales)
Sedoreoviridae
Cryo-EMreconstruction of arotavirus
Virus classificationEdit this classification
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum: Duplornaviricota
Class: Resentoviricetes
Order: Reovirales
Family: Sedoreoviridae
Subfamilies and genera

see text

Sedoreoviridae (formerlyReoviridae) is afamilyofdouble-stranded RNA viruses.Member viruses have a widehostrange, includingvertebrates,invertebrates,plants,protistsand fungi.[1]They lack lipidenvelopesand package their segmented genome within multi-layeredcapsids.Lack of a lipid envelope has allowedthree-dimensional structuresof these large complex viruses (diameter ~60–100nm) to be obtained, revealing a structural and likely evolutionary relationship to thecystovirusfamily ofbacteriophage.[2]There are currently 97speciesin this family, divided among 15generain two subfamilies.[3]Reoviruses can affect thegastrointestinal system(such asrotaviruses) andrespiratory tract.[4]The name "reo-" is anacronymfor "respiratoryentericorphan "viruses.[5]The term "orphan virus"refers to the fact that some of these viruses have been observed not associated with any known disease. Even though viruses in the familyReoviridaehave more recently been identified with various diseases, the original name is still used.

Reovirus infections occur often in humans, but most cases are mild or subclinical.Rotaviruses,however, can cause severediarrheaand intestinal distress in children, and lab studies in mice have implicatedorthoreovirusesin the expression ofcoeliac diseasein pre-disposed individuals.[6]The virus can be readily detected infeces,and may also be recovered frompharyngealornasal secretions,urine,cerebrospinal fluid,and blood. Despite the ease of finding reoviruses in clinical specimens, their role in human disease or treatment is still uncertain.

Some viruses of this family, such asphytoreovirusesandoryzaviruses,infect plants. Most of the plant-infecting reoviruses are transmitted between plants byinsect vectors.The virusesreplicatein both the plant and the insect, generally causing disease in the plant, but little or no harm to the infected insect.[7]: 148 

Structure

[edit]
Structure of a reovirus

Reoviruses are non-enveloped and have anicosahedralcapsidcomposed of an outer (T=13) and inner (T=2) protein shell.[1][8]Ultrastructure studies show that virion capsids are composed of two or three separate layers which depends on species type. The innermost layer (core) has T=1 icosahedral symmetry and is composed of 60 different types of structural proteins. The core contains the genome segments, each of them encode a variety enzyme structure which is required for transcription. The core is covered by capsid layer T=13 icosahedral symmetry. Reoviruses have a unique structure which is contains a glycolisated spike protein on the surface.[9]

Genome

[edit]

The genomes of viruses in familyReoviridaecontain 9–12 segments which are grouped into three categories corresponding to their size: L (large), M (medium) and S (small). Segments range from about 0.2 to 3 kbp and each segment encodes 1–3 proteins (10–14 proteins in total[1]). Proteins of viruses in the familyReoviridaeare denoted by the Greek character corresponding to the segment it was translated from (the L segment encodes for λ proteins, the M segment encodes for μ proteins and the S segment encodes for σ proteins).[8]

Life cycle

[edit]
Life cycle of a reovirus

Viruses in the familyReoviridaehave genomes consisting of segmented,double-stranded RNA(dsRNA).[4]Because of this, replication occurs exclusively in the cytoplasm, and the virus encodes several proteins which are needed for replication and conversion of the dsRNA genome into positive-sense RNAs.[10]

The virus can enter the host cell via a receptor on the cell surface. The receptor is not known but is thought to includesialic acidandjunctional adhesion molecules(JAMs).[10]The virus is partially uncoated by proteases in the endolysosome, where the capsid is partially digested to allow further cell entry. The core particle then enters the cytoplasm by a yet unknown process where the genome is transcribed conservatively causing an excess of positive-sense strands, which are used asmessenger RNAtemplates to synthesize negative-sense strands.[10]

The genome of the rotavirus is divided into 11 segments. These segments are associated with the VP1 molecule which is responsible for RNA synthesis. In early events, the selection process occurs so that the entry of the 11 different RNA segments go in the cell. This procedure is performed by newly synthesized RNAs. This event ensures that one each of the 11 different RNA segments is received. In late events, the transcription process occurs again but this time is not capped unlike the early events. For virus different amounts of RNAs are required therefore during the translation step there is a control machinery. There are the same quantities of RNA segments but different quantities of proteins. The reason for this is that the RNA segments are not translated at the same rate.[7]

Viral particles begin to assemble in the cytoplasm 6–7 hours after infection. Translation takes place by leaky scanning, suppression of termination, andribosomal skipping.The virus exits the host cell by monopartite non-tubule guided viral movement, cell to cell movement, and existing in occlusion bodies after cell death and remaining infectious until finding another host.[1]

Multiplicity reactivation

[edit]

Multiplicity reactivation(MR) is the process by which two or more virus genomes, each containing inactivating genome damage, can interact within an infected cell to form a viable virus genome. McClain and Spendlove[11]demonstrated MR for three types of reovirus after exposure to ultraviolet irradiation. In their experiments, reovirus particles were exposed to doses of UV-light that would be lethal in single infections. However, when two or more inactivated viruses were allowed to infect individual host cells MR occurred and viable progeny were produced. As they stated, multiplicity reactivation by definition involves some type of repair. Michod et al.[12]reviewed numerous examples of MR in different viruses, and suggested that MR is a common form of sexual interaction in viruses that provides the benefit of recombinational repair of genome damages.[citation needed]

Taxonomy

[edit]

The familyReoviridaeis divided into two subfamilies[13]based on the presence of a "turret" protein on the inner capsid.[14][15]From ICTV communications: "The nameSpinareovirinaewill be used to identify the subfamily containing the spiked or turreted viruses and is derived from 'reovirus' and the Latin word 'spina' as a prefix, which means spike, denoting the presence of spikes or turrets on the surface of the core particles. The term 'spiked' is an alternative to 'turreted', that was used in early research to describe the structure of the particle, particularly with the cypoviruses. The nameSedoreovirinaewill be used to identify the subfamily containing the non-turreted virus genera and is derived from 'reovirus' and the Latin word 'sedo', which means smooth, denoting the absence of spikes or turrets from the core particles of these viruses, which have a relatively smooth morphology. "[16]

Phylogenetic treeof familyReoviridae,dashed line divides subfamilySedoreovirinaeandSpinareovirinae

The familyReoviridaeis divided into the following subfamilies and genera:

Therapeutic applications

[edit]

Although reoviruses are mostly nonpathogenic in humans, these viruses have served as very productive experimental models for studies ofviral pathogenesis.[17]Newborn mice are extremely sensitive to reovirus infections and have been used as the preferred experimental system for studies of reovirus pathogenesis.[2]

Reoviruses have been demonstrated to haveoncolytic(cancer-killing) properties, encouraging the development of reovirus-based therapies for cancer treatment.[18][19][20]

Reolysinis a formulation of reovirus (Mammalian orthoreovirusserotype 3-dearing strain[21]) that is currently in clinical trials for the treatment of various cancers,[22]including studies currently developed to investigate the role of Reolysin combined with other immunotherapies.[21]

See also

[edit]

References

[edit]
  1. ^abcd"Viral Zone".ExPASy.Retrieved15 June2015.
  2. ^abGuglielmi, KM; Johnson, EM; Stehle, T; Dermody, TS (2006). "Attachment and Cell Entry of Mammalian Orthoreovirus".Reoviruses: Entry, Assembly and Morphogenesis.Current Topics in Microbiology and Immunology. Vol. 309. pp. 1–38.doi:10.1007/3-540-30773-7_1.ISBN978-3-540-30772-3.PMID16909895.{{cite book}}:|journal=ignored (help)
  3. ^"Virus Taxonomy: 2019 Release".talk.ictvonline.org.International Committee on Taxonomy of Viruses.Retrieved11 May2020.
  4. ^abPatton JT, ed. (2008).Segmented Double-stranded RNA Viruses: Structure and Molecular Biology.Caister Academic Press.ISBN978-1-904455-21-9.
  5. ^Fenner, F (June 1976)."The classification and nomenclature of viruses. Summary of results of meetings of the International Committee on Taxonomy of Viruses in Madrid, September 1975".Virology.71(2): 371–8.doi:10.1016/0042-6822(76)90364-0.PMC7131526.PMID820065.
  6. ^Bouziat, R; et al. (April 7, 2017)."Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease".Science.356(6333): 44–50.Bibcode:2017Sci...356...44B.doi:10.1126/science.aah5298.PMC5506690.PMID28386004.
  7. ^abCarter, John; Saunders, Venetia (2007).Virology: Principles and Applications.West Sussex: Wiley.ISBN978-0-470-02386-0.
  8. ^ab"Reoviruses".MicrobiologyBytes.Archived fromthe originalon 2015-05-21.
  9. ^Payne S (2017)."Family Reoviridae".Viruses:219–226.doi:10.1016/B978-0-12-803109-4.00026-X.ISBN9780128031094.
  10. ^abcBarton, ES; Forrest, JC; Connolly, JL; Chappell, JD; Liu, Y; Schnell, FJ; Nusrat, A; Parkos, CA; Dermody, TS (February 9, 2001)."Junction adhesion molecule is a receptor for reovirus".Cell.104(3): 441–51.doi:10.1016/S0092-8674(01)00231-8.PMID11239401.
  11. ^McClain ME, Spendlove RS (November 1966)."Multiplicity reactivation of reovirus particles after exposure to ultraviolet light".J. Bacteriol.92(5): 1422–9.doi:10.1128/JB.92.5.1422-1429.1966.PMC276440.PMID5924273.
  12. ^Michod, R. E.; Bernstein, H.; Nedelcu, A. M. (2008). "Adaptive value of sex in microbial pathogens".Infection, Genetics and Evolution.8(3): 267–285.doi:10.1016/j.meegid.2008.01.002.PMID18295550.
  13. ^Carstens, E. B. (January 2010)."Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2009)".Archives of Virology.155(1): 133–146.doi:10.1007/s00705-009-0547-x.PMC7086975.PMID19960211.
  14. ^Hill C, Booth T, et al. (1999). "The structure of a cypovirus and the functional organization of dsRNA viruses".Nature Structural Biology.6(6): 565–9.doi:10.1038/9347.PMID10360362.S2CID28217302.
  15. ^Knipe D, Howley P, et al. (2006).Fields Virology.Philadelphia, Pa.: Wolters Kluwer, Lippincott Williams & Wilkins. p. 1855.ISBN978-0-7817-6060-7.
  16. ^Attoui, Houssam; Mertens, Peter."Template for Taxonomic Proposal to the ICTV Executive Committee To create a new SubFamily in an existing Family".International Committee on Taxonomy of Viruses.2007.127-129V.v2.Spina-Sedoreovirinae. pp. 1–9. Archived fromthe originalon March 5, 2010.
  17. ^Acheson, Nicholas H.Fundamentals of Molecular Virology.John Wiley and Sons (2011). p.234
  18. ^Kanai, Yuta; Kobayashi, Takeshi (29 September 2021)."FAST Proteins: Development and Use of Reverse Genetics Systems for Reoviridae Viruses".Annual Review of Virology.8(1): 515–536.doi:10.1146/annurev-virology-091919-070225.ISSN2327-056X.PMID34586868.
  19. ^Lal R, Harris D,Postel-Vinay S,de Bono J (October 2009). "Reovirus: Rationale and clinical trial update".Curr. Opin. Mol. Ther.11(5): 532–9.PMID19806501.
  20. ^Kelland, K. (13 June 2012)."Cold virus hitches a ride to kill cancer: study".Reuters.Retrieved17 June2012.
  21. ^abBabiker, H.M.; Riaz, I.B.; Husnain, M.; Borad, M.J. (February 2017)."Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma".Oncolytic Virotherapy.6.Dovepress, New Zealand NLM: 11–18.doi:10.2147/OV.S100072.ISSN2253-1572.PMC5308590.PMID28224120.101629828.
  22. ^Thirukkumaran C, Morris DG (2009). "Oncolytic Viral Therapy Using Reovirus".Gene Therapy of Cancer.Methods in Molecular Biology. Vol. 542. pp. 607–34.doi:10.1007/978-1-59745-561-9_31.ISBN978-1-934115-85-5.PMID19565924.
[edit]